Replies to post #139229 on Biotech Values

[jq1234]

PCSK9:

I Agree.

I wonder if PCSK9 antibodies work in Homozygous Familial Hypercholesterolemia and/or Heterozygous familial hypercholesterolemia at the same degree current data show, the indications SNY's mipomersen and AEGR's lomitapide are trying to get approval.